Chapter 27 : Epstein-Barr Virus Infection and Primary Central Nervous System Lymphoma

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in

Epstein-Barr Virus Infection and Primary Central Nervous System Lymphoma, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555815691/9781555813697_Chap27-1.gif /docserver/preview/fulltext/10.1128/9781555815691/9781555813697_Chap27-2.gif


Epstein-Barr virus (EBV) is a double-stranded DNA virus of 172 kbp. It is classified as a lymphocryptovirus in the gammaherpesvirus group. Infection with EBV is very common, usually occurring early in life, and is endemic in all human populations. There are two main types of EBV infection, lytic and latent. The infection occurs even in populations that are geographically isolated, thus indicating that EBV is a fairly ancient virus. Encephalitis is an uncommon manifestation of acute EBV infection but is well described. The diagnosis of EBV-related disease must be planned thoughtfully, choosing appropriate methods to answer well-defined questions. Primary central nervous system (CNS) lymphomas (PCNSL) is an EBV-associated opportunistic neoplasm of the brain found in patients with very advanced HIV disease, having very low CD4+ T-cell counts. This is the most common CNS manifestation of EBV infection in AIDS patients, although with the advent of highly effective combination antiretroviral therapy, the disease has become quite uncommon. Infection with EBV is common and lifelong in humans and rarely results in severe disease. Treatment of opportunistic neoplasms is difficult, and the prognosis is still not very good despite the progress that has been made in understanding these tumors. On the other hand, recent basic research has suggested a number of new approaches, and much clinical trial work remains to be done.

Citation: Tselis A, McKendall R. 2009. Epstein-Barr Virus Infection and Primary Central Nervous System Lymphoma, p 383-391. In Goodkin K, Shapshak P, Verma A (ed), The Spectrum of Neuro-AIDS Disorders. ASM Press, Washington, DC. doi: 10.1128/9781555815691.ch27
Highlighted Text: Show | Hide
Loading full text...

Full text loading...


1. Aboulafia, D. 2002. Interleukin-2, ganciclovir, and high-dose zidovudine for the treatment of AIDS-associated primary central nervous system lymphoma. Clin. Infect. Dis. 34: 16601662.
2. Adamson, D.,, and P. Gordon. 1992. Hemiplegia—a rare complication of acute Epstein-Barr virus (EBV) infection. Scand. J. Infect. Dis. 24: 7980.
3. Antinori, A.,, A. Ammassari,, A. De Luca,, A. Cingolani,, R. Murri,, G. Scoppettuolo,, M. Fortini,, T. Tartaglione,, K. M. Larocca,, G. Zannoni,, P. Cattani,, R. Grillo,, R. Roselli,, M. Iacoangeli,, M. Scerrati, and, L. Ortona. 1997. Diagnosis of AIDS-related focal brain lesions: a decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF. Neurology 48: 8794.
4. Antinori, A.,, G. De Rossi,, A. Ammassari,, A. Cingolani,, R. Murri,, D. Di Giuda,, A. De Luca,, F. Pierconti,, T. Tartaglione,, M. Scerrati,, L. M. Larocca, and, L. Ortona. 1999. Value of combined approach with thallium-201 single-photon emission computed tomography and Epstein-Barr virus DNA polymerase chain reaction in CSF for the diagnosis of AIDS-related primary CNS lymphoma. J. Clin. Oncol. 17: 5460.
5. Baker, F.,, G. S. Kotchmar, Jr.,, W. S. Foshee, and, C. V. Sumaya. 1983. Acute hemiplegia of childhood associated with Epstein-Barr virus infection. Pediatr. Infect. Dis. J. 2: 3638.
6. Baumgartner, J.,, J. Rachlin,, J. H. Beckstead,, T. C. Meeker,, R. M. Levy,, W. M. Wara, and, M. L. Rosenblum. 1990. Primary central nervous system lymphomas: natural history and response to radiation therapy in 55 patients with acquired immunodeficiency syndrome. J. Neurosurg. 73: 206211.
7. Bingham, J. 2002. Where can FDG-PET contribute most to anatomical imaging problems. Br. J. Radiol. 75 (Spec. no.): S32S59.
8. Burkitt, D. 1958. A sarcoma involving the jaws in African children. Br. J. Surg. 46: 218223.
9. Camilleri-Broet, S.,, F. Davi,, J. Feuillard,, D. Seilhean,, J. F. Michiels,, P. Brousset,, B. Epardeau,, E. Navratil,, K. Mokhtari,, C. Bourgeois,, L. Marelle,, M. Raphael, and, J. J. Hauw. 1997. AIDS-related primary brain lymphomas: histopathologic and immunohistochemical study of 51 cases. Hum. Pathol. 28: 367374.
10. Carter, R.,, and H. Penman. 1969. The early history of infectious mononucleosis and its relation to “glandular fever,” p. 1–18. In R. Carter and, H. Penman (ed.), Infectious Mononucleosis. Blackwell Scientific Publications, Oxford, United Kingdom.
11. Chang, L.,, B. L. Miller,, D. McBride,, M. Cornford,, G. Oropilla,, S. Buchthal,, F. Chiang,, H. Aronow,, C. K. Beck, and, T. Ernst. 1995. Brain lesions in patients with AIDS: H-1 MR spectroscopy. Radiology 197: 525531.
12. Cinque, P.,, M. Brytting,, L. Vago,, A. Castagna,, C. Parravicini,, N. Zanchetta,, A. D’Arminio Monforte,, B. Wahren,, A. Lazzarin, and, A. Linde. 1993. Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system. Lancet 342: 398401.
13. Cohen, J. 1997. Epstein-Barr virus and the immune system. Hide and seek. JAMA 278: 510513.
14. Cohen, J. 2000. Epstein-Barr virus infection. N. Engl. J. Med. 343: 481492.
15. Cohen, J. 2005. HMG CoA reductase inhibitors (statins) to treat Epstein-Barr virus-driven lymphoma. Br. J. Cancer 92: 15931598.
16. Colby, B.,, J. Shaw,, G. B. Elion, and, J. S. Pagano. 1980. Effect of acyclovir on Epstein-Barr virus DNA replication. J. Virol. 34: 560568.
17. Copperman, S. 1977. “Alice in Wonderland” syndrome as a presenting symptom of infectious mononucleosis in children. Clin. Pediatr. (Philadelphia) 16: 143146.
18. d’Arminio Monforte, A.,, P. Cinque,, L. Vago,, A. Rocca,, A. Castagna,, C. Gervasoni,, M. R. Terreni,, R. Novati,, A. Gori,, A. Lazzarin, and, M. Moroni. 1997. A comparison of brain biopsy and CSF-PCR in the diagnosis of CNS lesions in AIDS patients. J. Neurol. 244: 3539.
19. Davis, C.,, B. L. Wood,, D. E. Sabath,, J. S. Joseph,, C. Stehman-Breen, and, V. C. Broudy. 1998. Interferon-alpha treatment of posttransplant lymphoproliferative disorder in recipients of solid organ transplants. Transplantation 66: 17701779.
20. DeSimone, P.,, and D. Snyder. 1978. Hypoglossal nerve paralysis in infectious mononucleosis. Neurology 28: 844847.
21. de-The, G.,, A. Geser,, N. E. Day,, P. M. Tukei,, E. H. Williams,, D. P. Beri,, P. G. Smith,, A. G. Dean,, G. W. Bronkamm,, P. Feorino, and, W. Henle. 1978. Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt’s lymphoma from Ugandan prospective study. Nature 274: 756761.
22. Epstein, M.,, B. Achong, and, Y. M. Barr. 1964. Virus particles in cultured lymphoblasts from Burkitt’s lymphoma. Lancet 15: 702703.
23. Eshel, G.,, A. Eyov,, E. Lahat, and, A. Brauman. 1987. Alice in Wonderland syndrome, a manifestation of acute Epstein-Barr virus infection. Pediatr. Infect. Dis. J. 6: 68.
24. Evans, A.,, J. C. Niederman, and, R. W. McCollum. 1968. Seroepidemiologic studies of infectious mononucleosis with EB virus. N. Engl. J. Med. 279: 11211127.
25. Faro, A.,, G. Kurland,, M. G. Michaels,, P. S. Dickman,, P. G. Greally,, K. J. Spichty,, B. B. Noyes,, S. R. Boas,, F. J. Fricker,, J. M. Armitage, and, A. Zeevie. 1996. Interferon alpha effects the immune response in post-transplant lymphoproliferative disorder. Am. J. Respir. Crit. Care Med. 153: 14421447.
26. Gottschalk, S.,, C. Rooney, and, H. E. Heslop. 2005. Post-transplant lymphoproliferative disorders. Annu. Rev. Med. 56: 2944.
27. Grose, C.,, and P. Feorino. 1972. Epstein-Barr virus and Guillain-Barre syndrome. Lancet ii: 12851287.
28. Grose, C.,, P. Feorino,, L. A. Dye, and, J. Rand. 1973. Bell’s palsy and infectious mononucleosis. Lancet ii: 231232.
29. Haddad, E.,, S. Paczesny,, V. Leblond,, J. M. Seigneurin,, M. Stern,, A. Achkar,, M. Bauwens,, V. Delmail,, D. Debray,, C. Duvoux,, P. Hubert,, B. Hurault de Ligny,, J. Wijdenes,, A. Durandy, and, A. Fischer. 2001. Treatment of B-lymphoproliferative disorder with a monoclonal anti-interleukin-6 antibody in 12 patients: a multicenter phase 1-2 clinical trial. Blood 87: 16801687.
30. Henle, G.,, W. Henle, and, V. Diehl. 1968. Relation of Burkitt’s tumor-associated herpes-type virus to infectious mononucleosis. Proc. Natl. Acad. Sci. USA 59: 94101.
31. Herbst, H. 1996. Epstein-Barr virus in Hodgkin’s disease. Semin. Cancer Biol. 7: 183189.
32. Hjalgrim, H.,, J. Askling,, K. Rostgaard,, S. Hamilton-Dutoit,, M. Frisch,, J. S. Zhang,, M. Madsen,, N. Rosadhl,, H. B. Konradsen,, H. H. Storm, and, M. Melbye. 2003. Characteristics of Hodgkin’s lymphoma after infectious mononucleosis. N. Engl. J. Med. 349: 13241332.
33. Hoagland, R. 1967. Infectious Mononucleosis. Grune and Stratton, New York, NY.
34. Hoffman, C.,, S. Tabrizian,, E. Wolf,, C. Eggers,, A. Stoehr,, A. Plettenberg,, T. Buhk,, H. J. Stellbrink,, H. A. Horst,, H. Jager, and, T. Rosenkranz. 2001. Survival of AIDS patients with primary central nervous system lymphoma is dramatically improved by HAART-induced immune recovery. AIDS 15: 21192127.
35. Hoffman, J. M.,, H. A. Waskin,, T. Schifter,, M. W. Hanson,, L. Gray,, S. Rosenfeld, and, R. E. Coleman. 1993. FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS. J. Nucl. Med. 34: 567575.
36. Jones, J. F.,, S. Shurin,, C. Abramowsky,, R. R. Tubbs,, C. G. Sciotto,, R. Wahl,, J. Sands,, D. Gottman,, B. Z. Katz, and, J. Sklar. 1988. T-cell lymphomas containing Epstein-Barr viral DNA in patients with Epstein-Barr virus infections. N. Engl. J. Med. 318: 733741.
37. Kieff, E.,, T. Dambaugh,, M. Heller,, W. King,, A. Cheung,, V. van Santen,, M. Hummel,, C. Beisel,, S. Fennewald,, K. Hennessy, and, T. Heineman. 1982. The biology and chemistry of Epstein-Barr virus. J. Infect. Dis. 146: 506517.
38. Leavell, R.,, C. G. Ray,, P. C. Ferry, and, L. L. Minnich. 1986. Unusual acute neurological presentations with Epstein-Barr virus infection. Arch. Neurol. 43: 186188.
39. Levitsky, V.,, T. Frisan, and, M. Masucci. 2001. Generation of polyclonal EBV-specific CTL cultures and clones, p. 203–208. In J. Wilson and, G. May (ed.), Epstein-Barr Virus Protocols, vol. 174. Humana Press, Totowa, NJ.
40. MacMahon, E.,, J. D. Glass,, S. D. Hayward,, R. B. Mann,, P. S. Becker,, P. Charache,, J. C. McArthur, and, R. F. Ambinder. 1991. Epstein-Barr virus in AIDS-related primary CNS lymphoma. Lancet 338: 969973.
41. McGowan, J.,, and S. Shah. 1998. Long-term remission of AIDS-related primary central nervous system lymphoma associated with highly active antiretroviral therapy. AIDS 12: 952954.
42. Mentzer, S.,, S. Perrine, and, D. V. Faller. 2001. Epstein-Barr virus post-transplant lymphoproliferative disease and virus-specific therapy: pharmacological re-activation of viral target genes with arginine butyrate. Transplant. Infect. Dis. 3: 177185.
43. Niedobitek, G.,, and H. Herbst. 2006. Pathology of primary and persistent EBV infection, p. 59–78. In A. Tselis and, H. Jenson (ed.), Epstein-Barr Virus. Taylor and Francis, New York, NY.
44. Old, L. J.,, E. A. Boyse,, G. Geering, and, H. F. Oettegen. 1968. Serologic approaches to the study of cancer in animals and in man. Cancer Res. 28: 12881299.
45. O’Malley, J. P.,, H. A. Ziessman,, P. N. Kumar,, B. A. Harkness,, J. G. Tall, and, P. F. Poerce. 1994. Diagnosis of intracranial lymphoma in patients with AIDS: value of 201Tl single-photon emission computed tomography. AJR Am. J. Roentgenol. 163: 412421.
46. Palella, F.,, K. M. Delaney,, A. C. Moorman,, M. O. Loveless,, J. Fuhrer,, G. A. Satten,, D. J. Aschman, and, S. D. Holmberg. 1998. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N. Engl. J. Med. 338: 853860.
47. Paul, J.,, and W. Bunnell. 1932. The presence of heterophile antibodies in infectious mononucleosis. Am. J. Med. Sci. 183: 191194.
48. Rubenstein, J.,, D. Combs,, J. Rosenberg,, A. Levy,, M. McDermott,, L. Damon,, R. Ignoffo,, K. Aldape,, A. Shen,, D. Lee,, A. Grillo-Lopez, and, M. A. Shuman. 2003. Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment. Blood 101: 466468.
49. Sharma, K.,, S. Sriram,, T. Fries,, H. J. Bevan, and, W. G. Bradley. 1993. Lumbosacral radiculoplexopathy as a manifestation of Epstein-Barr virus infection. Neurology 43: 25502554.
50. Skiest, D. 2002. Focal neurological disease in patients with acquired immunodeficiency syndrome. Clin. Infect. Dis. 34: 103115.
51. Skiest, D.,, and C. Crosby. 2003. Survival is prolonged by highly active antiretroviral therapy in AIDS patients with primary central nervous system lymphoma. AIDS 17: 17871793.
52. So, Y.,, J. Beckstead, and, R. L. Davis. 1986. Primary central nervous system lymphoma in acquired immune deficiency syndrome: a clinical and pathological study. Ann. Neurol. 20: 566572.
53. Spano, J.,, P. Busson,, D. Atlan,, J. Bourhis,, J. P. Pignon,, C. Esteban, and, J. P. Armand. 2003. Nasopharyngeal carcinomas: an update. Eur. J. Cancer 39: 21212135.
54. Spina, M.,, U. Jaeger,, J. A. Sparano,, C. Simonelli,, M. Michieli,, G. Rossi,, E. Nigra,, M. Barretta,, C. Cattaneo,, A. C. Rieger,, E. Vaccher, and, U. Tirelli. 2005. Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: pooled results from 3 phase 2 trials. Blood 105: 18911897.
55. Sprunt, T.,, and F. Evans. 1920. Mononuclear leucocytosis in reaction to acute infections (infectious mononucleosis). Johns Hopkins Hosp. Bull. 357: 410416.
56. Straathof, K.,, C. M. Bollard,, C. M. Rooney, and, H. E. Heslop. 2003. Immunotherapy for Epstein-Barr virus-associated cancers in children. Oncologist 8: 8398.
57. Taylor, L.,, and G. Parsons-Smith. 1969. Infectious mononucleosis, deafness and facial paralysis. J. Laryngol. Otol. 83: 613616.
58. Thurnher, M.,, A. Rieger,, C. Kleibl-Popov,, U. Settinek,, C. Henk,, C. Haberler, and, E. Schindler. 2001. Primary central nervous system lymphoma in AIDS: a wider spectrum of CT and MRI findings. Neuroradiology 43: 2935.
59. Tossing, G. 1996. Immunodeficiency and its relation to lymphoid and other malignancies. Ann. Hematol. 73: 163167.
60. Villringer, K.,, H. Jager,, M. Dichgans,, S. Ziegler,, J. Poppinger,, M. Herz,, C. Kruschke,, S. Minoshima,, H. W. Pfister, and, M. Schwaiger. 1995. Differential diagnosis of CNS lesions in AIDS patients by FDG-PET. J. Comput. Assist. Tomogr. 19: 532536.
61. Watson, P.,, and P. Ashby. 1976. Brachial plexus neuropathy associated with infectious mononucleosis. Can. Med. Assoc. J. 114: 758759.
62. Ziegler, J. L.,, J. A. Beckstead,, P. A. Volberding,, D. I. Abrams,, A. M. Levine,, R. J. Lukes,, P. S. Gill,, R. L. Burkes,, P. R. Meyer,, C. E. Metroka, et al. 1984. Non-Hodgkin’s lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. N. Engl. J. Med. 311: 565570.
63. zur Hausen, H.,, H. Schulte-Holthausen,, G. Klein,, G. W. Henle,, G. Henle,, P. Clifford, and, L. Santensson. 1970. EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature 228: 10561058.


Generic image for table

EBV latency expression

Citation: Tselis A, McKendall R. 2009. Epstein-Barr Virus Infection and Primary Central Nervous System Lymphoma, p 383-391. In Goodkin K, Shapshak P, Verma A (ed), The Spectrum of Neuro-AIDS Disorders. ASM Press, Washington, DC. doi: 10.1128/9781555815691.ch27
Generic image for table

Serology in EBV infection

Citation: Tselis A, McKendall R. 2009. Epstein-Barr Virus Infection and Primary Central Nervous System Lymphoma, p 383-391. In Goodkin K, Shapshak P, Verma A (ed), The Spectrum of Neuro-AIDS Disorders. ASM Press, Washington, DC. doi: 10.1128/9781555815691.ch27

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error